ClinicalTrials.gg
Enrolling by invitationNCT06492057Easymotion-2Updated Mar 23, 2026

Electromyostimulation (EMS) of Astronauts in Spaceflight (Easymotion-2)

An interventional study of Electromyostimulation (EMS) and Myoton in Muscle Atrophy, Myotonia and Stiffness; Spine, sponsored by Charite University, Berlin, Germany. Enrolling by invitation at 1 site in Germany. Open to participants aged 40 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-23.

Sponsored by Charite University, Berlin, Germany · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
40 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Muscular Atrophy with a site in Germany — 7 open to participants now, 8 under way, 1 of them phase 3. Muscular Atrophy · Germany.

Planned enrollment
18th of 21
12 · median 130
Started
2025
the only one that year
No phase
16 of 23
7 open now
Registered
18th of 23
by date
Lead sponsor
1 of 23
Charite University, Berlin, Germany

Among the 23 studies in Muscular Atrophy with a site in Germany, this one is the 18th largest by planned enrollment of the 21 interventional ones that give a count, is the only one that started in 2025, is one of 16 with no phase, and was the 18th registered.

Muscular Atrophy

413 studies on the registry are indexed under Muscular Atrophy; 76 are open to participants now.

Browse Muscular Atrophy studies →

Open to participants now

7 of the 23 studies in Muscular Atrophy with a site in Germany are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 51 Muscular Atrophy studies recruiting now, 25 (49%) set no upper age limit and 13 (25%) stop at 75 or younger; 4 take children under 18; 16 take healthy volunteers.

This study: 40 Years to 60 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Muscular Atrophy with a site in Germany, or all of them as a file.
02

Study summary

This is a prospective spaceflight study involving an investigational non-risk device called the EasyMotionSkin for whole body electric muscle (myo) stimulation (WB-EMS) onboard the International Space Station (ISS).

The purpose of this study is to show:

  • optimized exercise outcome with EMS in human spaceflight
  • demonstrate efficacy of EMS as alternative inflight exercise protocol
  • provide a time-saving and reliable EMS-assisted exercise protocol compliant to astronauts for later use in planetary habitats and future deep space exploration

Eight (n=8) astronauts on long duration missions will take part in this study. This experiment uses the following hardware/software (HW \& SW): (A) EasymotionSkin suit (dry electrode muscle stimulation), B) non-invasive hand-held Myoton device (digitized passive muscle stiffness data collection). C) a customized Myoton body template suit (elastic yoga suit with customized anatomical reference labels to aid inflight Myoton data collection on dedicated perforated 2x2 cm small skin fields) at 5 different skin measurement points (MP), neck, back, shoulder, legs.

Before and after flight the following tests will be done once: Myoton data collection, dynamometry strength test, magnetic resonance imaging (MRI) for baseline comparison. Researchers will compare data from a non EMS control group (non EMS Astronauts, retrospective) to see if changes of passive muscle stiffness is seen in EMS Astronauts before, during and after spaceflight

Read the detailed description

In a previous space analog study (60 days reactive jumps on a sledge during bed rest immobilisation, Cologne, Germany, 2015) on n=24 voluntary participants followed by an experiment on the International Space Station, ISS (MYOTONES 2015-2023) the investigators used non-invasive Myoton technology (Myoton device) to detect digital biomarkers (passive muscle tone and stiffness) on twelve (n=12) study participants together with clinical imaging (MRI), muscle strength tests (dynamometry), and blood samples (biosamples) to study muscle properties and adaptation in microgravity following routine inflight exercise in ISS Astronauts. One of the MYOTONES ISS Astronaut already tested a space-qualified EasymotionSkin suit (Demo-Tech Experiment, German Aerospace Agency, Deutsches Zentrum fuer Luft- und Raumfahrt, DLR, 2022) that was used for about 20 minutes on top of the daily routine exercise protocol in order to optimize inflight training outcome by EMS technology in spaceflight. Preliminary results (n=1) showed feasibility of the novel EMS technology in spaceflight and suggested improved muscle health parameters (increased tone and stiffness) found in some muscle from torso (lower back) and limbs compared to a non-EMS mission crewmember. Easymotion-2 is designed to replicate similar changes in inflight passive muscle parameters (resembling muscle health) in eight (n=8) more ISS Astronauts for robust statistical analyses and interpretation. Pre and postflight baseline data collections with Myoton technology (passive tone [Hz] and stiffness [N/m]) serve as control for comparison. Protocol and recruitment of healthy study participants (male or female Astronauts) is under control by NASA via Informed Consent Briefing standardized procedures.

03

Conditions studied

  • Muscle Atrophy
  • Myotonia
  • Stiffness; Spine
  • Exercise Overtraining

Keywords

  • skeletal muscle
  • passive muscle stiffness
  • muscle health
  • electromyostimulation
  • space flight
  • countermeasure
04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Astronauts with active Flight Medical

Exclusion criteria

Exclusion Criteria:

  • Heart disease
  • Liver disease
  • Diabetes
  • Thrombosis
  • Extreme blood pressure
  • Abdominal \& inguinal hernias (bulges)
  • Strong neurological diseases
  • Pregnancy
  • Cancer
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    EMS (electromyostimulation) participants

    Healthy Astronauts that perform EMS-assisted inflight exercise onboard the International Space Station

    Device: Electromyostimulation (EMS) · Device: Myoton · Diagnostic Test: Electromyography (EMG) · Diagnostic Test: Magnetic Resonance Imaging (MRI) · Diagnostic Test: Dynamometry

Interventions

  • DeviceElectromyostimulation (EMS)

    EasymotionSkin body suit for digitally controlled electric impulses via Easymotion-2 software on crew iPad (frequency, impulse rate, duration) are transferred from integrated dry electrodes of the EMS- stimulation suit to activate surface muscle groups of the body (trunk), arms and legs

    Also known as: EMS body muscle stimulation

  • DeviceMyoton

    The non-invasive Myoton technology collects data from passive muscle properties (tone and stiffness) obtained from selected anatomical surface muscle groups

    Also known as: passive muscle properties

  • Diagnostic testElectromyography (EMG)

    As a standard method, surface EMG collects data from nerve impulse-triggered active muscle contractions, pre/postflight only

    Also known as: surface EMG/nerve impulse rate [amplitude/frequency]

  • Diagnostic testMagnetic Resonance Imaging (MRI)

    MRI is a clinically standard (non-radiation) imaging method to study structural changes of the human body (organs, muscle, bones, tendons) at the macroscopic level, pre/postflight only

    Also known as: MRI, Magnetic Resonance Tomography

  • Diagnostic testDynamometry

    Dynamometry is a standard functional and diagnostic method to test muscle strength in sports and rehabilitation. pre/postflight only

    Also known as: muscle functional test

06

What researchers measure

Primary outcomes

  1. Myoton Tone (baseline preflight)

    Passive muscle tone \[Hz\] numerical indices. Abbreviations for Outcome Measures 1-37: Hertz, Hz; Newton/meter, N/m; before launch (preflight), L-; recovery (postflight), R+; inflight days, FD; not earlier than, NET; not later than, NLT; electro-myo-stimulation, EMS; versus/against, vs; surface electromyography, sEMG.

    Time frame: L-105+/-30 days (time window)

  2. Myoton Tone (recovery postflight)

    Passive muscle tone \[Hz\] numerical indices. Abbreviations for Outcome Measures 1-37: Hertz, Hz; Newton/meter, N/m; before launch (preflight), L-; recovery (postflight), R+; inflight days, FD; not earlier than, NET; not later than, NLT; electromyostimulation, EMS; versus/against, vs; surface electromyography, sEMG.

    Time frame: R+30+/-10 days (time window)

  3. Myoton Tone (inflight, preEMS-1)

    Passive muscle tone \[Hz\] numerical indices. Abbreviations: see Outcome1

    Time frame: FD20-30 days (time window)

  4. Myoton Tone (inflight, preEMS-2)

    Passive muscle tone \[Hz\] numerical indices. Abbreviations: see Outcome1

    Time frame: FD60-80 days (time window)

  5. Myoton Tone (inflight, post EMS-1)

    Passive muscle tone \[Hz\] numerical indices. Abbreviations: see Outcome1

    Time frame: NET R-18 days (time window)

  6. Myoton Tone (inflight, post EMS-2)

    Passive muscle tone \[Hz\] numerical indices. Abbreviations: see Outcome1

    Time frame: NLT R-12 days (time window)

  7. Myoton stiffness (baseline, preflight).

    Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1

    Time frame: L-105+/-30 days (time window)

  8. Myoton stiffness (recovery, postflight).

    Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1

    Time frame: R+30+/-10 days (time window)

  9. Myoton stiffness (inflight, preEMS-1)

    Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1

    Time frame: FD20-30 days (time window)

  10. Myoton stiffness (inflight, preEMS-2)

    Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1

    Time frame: FD60-80 days (time window)

  11. Myoton stiffness (inflight, postEMS-1)

    Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1

    Time frame: NET R-18 days (time window)

  12. Myoton stiffness (inflight, postEMS-2)

    Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1

    Time frame: NLT R-12 days (time window)

  13. EMS body stimulation (inflight EMS1)

    1st out of a total of 12 (1/12) single EMS-assisted inflight exercise between NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24. Abbreviations: see Outcome 1.

    Time frame: NET R-60 and NLT R-21 days (time window)

  14. EMS body stimulation (inflight EMS2)

    2/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.

    Time frame: NET R-60 and NLT R-21 days (time window)

  15. EMS body stimulation (inflight EMS3)

    3/12 single EMS-assisted inflight exercise, NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.

    Time frame: NET R-60 and NLT R-21 days(time window)

  16. EMS body stimulation (inflight EMS4)

    4/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.

    Time frame: NET R-60 and NLT R-21 days (time window)

  17. EMS body stimulation (inflight EMS5)

    5/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.

    Time frame: NET R-60 and NLT R-21 days (time window)

  18. EMS body stimulation (inflight EMS6)

    6/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.

    Time frame: NET R-60 and NLT R-21 days (time window)

  19. EMS body stimulation (inflight EMS7)

    7/12 single EMS-assisted inflight exercise, NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.

    Time frame: NET R-60 and NLT R-21 days (time window)

  20. EMS body stimulation (inflight EMS8)

    8/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.

    Time frame: NET R-60 and NLT R-21 days (time window)

  21. EMS body stimulation (inflight EMS9)

    9/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.

    Time frame: NET R-60 and NLT R-21 days (time window)

  22. EMS body stimulation (inflight EMS10)

    10/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.

    Time frame: NET R-60 and NLT R-21 days (time window)

  23. EMS body stimulation (inflight EMS11)

    11/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.

    Time frame: NET R-60 and NLT R-21 days (time window)

  24. EMS body stimulation (inflight EMS12)

    Last out of a total of twelve (12/12) single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.

    Time frame: NET R-60 and NLT R-21 days (time window)

  25. Dynamometry (baseline, preflight/power).

    Standard muscle isometric/isokinetic tests (power \[Watt\] on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus). Abbreviations: see Outcome 1

    Time frame: L-105+/-30 days (time window)

  26. Dynamometry (baseline, preflight/torque).

    Standard muscle isometric/isokinetic tests ( torque \[Nm\]) on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus). Abbreviations: see Outcome 1

    Time frame: L-105+/-30 days (time window)

  27. sEMG (baseline, preflight/amplitude).

    Non-invasive sEMG by amplitude on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus) as part of dynamometry. Abbreviations: see Outcome 1

    Time frame: L-105+/-30 days (time window)

  28. sEMG (baseline, preflight/frequency).

    Non-invasive sEMG by frequency (Hz) on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus) as part of dynamometry. Abbreviations: see Outcome 1

    Time frame: L-105+/-30 days (time window)

  29. Dynamometry (recovery postflight/power).

    Standard muscle isometric/isokinetic tests (power \[Watt\] on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus). Abbreviations: see Outcome 1

    Time frame: R+30+/-10 days (time window)

  30. Dynamometry (recovery postflight/torque).

    Standard muscle isometric/isokinetic tests (torque \[Nm\] on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus). Abbreviations: see Outcome 1

    Time frame: R+30+/-10 days (time window)

  31. sEMG (recovery postflight/amplitude).

    Non-invasive surface EMG (amplitude) on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus) as part of dynamometry. Abbreviations: see Outcome 1

    Time frame: R+30+/-10 days (time window)

  32. sEMG (recovery postflight/frequency).

    Non-invasive surface EMG (Hz) on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus) as part of dynamometry. Abbreviations: see Outcome 1

    Time frame: R+30+/-10 days (time window)

  33. Magnetic Resonance Imaging (MRI) (baseline preflight).

    Standard clinical structural analysis by optical sections of lower leg and lumbar back muscle profile/volume area (square/3-D, centimeters). Abbreviations: see Outcome 1

    Time frame: L-105+/-30 days (time window)

  34. Magnetic Resonance Imaging (MRI) (recovery postflight).

    Standard clinical structural analysis by optical sections of lower leg and lumbar back muscle profile/volume area (square/3-D, centimeters). Abbreviations: see Outcome 1

    Time frame: R+30+/-10 days (time window)

  35. EMS protocol report (ms)

    Multiple measurements (milliseconds=ms) will be aggregated for each of the 12 single inflight EMS session (see Outcome 13-24) to report on inflight EMS protocol and to collect technical data (of muscle stimulation) for whole body inflight EMS monitoring and assessment. see Outcome1

    Time frame: NET R-60 and NLT R-21 days (time window)

  36. EMS protocol report (minutes)

    Multiple measurements (duration/min.) will be aggregated for each of the 12 single inflight EMS session (see Outcome 13-24) to report on inflight EMS protocol and to collect technical data (of muscle stimulation) for whole body inflight EMS monitoring and assessment. Abbreviations: see Outcome1

    Time frame: NET R-60 and NLT R-21 days (time window)

  37. EMS protocol report (Hz)

    Multiple measurements (frequency/Hz) will be aggregated for each of the 12 single inflight EMS session (see Outcome 13-24) to report on inflight EMS protocol and to collect technical data (of muscle stimulation) for whole body inflight EMS monitoring and assessment. Abbreviations: see Outcome1

    Time frame: NET R-60 and NLT R-21 days (time window)

07

Study locations

1 site
08

References and documents

Publications

  • Schoenrock B, Muckelt PE, Hastermann M, Albracht K, MacGregor R, Martin D, Gunga HC, Salanova M, Stokes MJ, Warner MB, Blottner D. Muscle stiffness indicating mission crew health in space. Sci Rep. 2024 Feb 20;14(1):4196. doi: 10.1038/s41598-024-54759-6. PubMed 38378866 ↗
  • Muckelt PE, Warner MB, Cheliotis-James T, Muckelt R, Hastermann M, Schoenrock B, Martin D, MacGregor R, Blottner D, Stokes M. Protocol and reference values for minimal detectable change of MyotonPRO and ultrasound imaging measurements of muscle and subcutaneous tissue. Sci Rep. 2022 Aug 11;12(1):13654. doi: 10.1038/s41598-022-17507-2. PubMed 35953503 ↗
  • Schoenrock B, Zander V, Dern S, Limper U, Mulder E, Veraksits A, Viir R, Kramer A, Stokes MJ, Salanova M, Peipsi A, Blottner D. Bed Rest, Exercise Countermeasure and Reconditioning Effects on the Human Resting Muscle Tone System. Front Physiol. 2018 Jul 3;9:810. doi: 10.3389/fphys.2018.00810. eCollection 2018. PubMed 30018567 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Results will not be shared to other researchers due to privacy reasons of participating Astronauts related to their Space Agencies

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Jul 2029, 46 months after the start.

Of 170 non-industry interventional studies with no phase under Muscular Atrophy, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 38. This study's planned 46 months is above that.

Counting every sponsor, half of 176 studies reached it within 21 months; a quarter within 9 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
May 23, 2024
First posted
Jul 9, 2024
StartActual
Sep 15, 2025
Primary completionEst.
Jul 31, 2029
CompletionEst.
Dec 31, 2029
Last update
Mar 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06492057
Collaborators
German Sport University, Cologne
Responsible party
Dieter Blottner (Professor Dr. (PhD), Charite University, Berlin, Germany) — Principal investigator
First posted
Jul 9, 2024
Start date
Sep 15, 2025
Primary completion
Jul 31, 2029 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Mar 23, 2026

Study contacts

Dieter Blottner, PhD
principal investigator · Charite-Universitätsmedizin Berlin, Germany

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion